Viewing Study NCT06391762



Ignite Creation Date: 2024-05-06 @ 8:28 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06391762
Status: COMPLETED
Last Update Posted: 2024-04-30
First Post: 2024-04-22

Brief Title: Level of Deprivation Assessment in a Population of Short-bowel Syndrome Patients With Intestinal Failure
Sponsor: Central Hospital Nancy France
Organization: Central Hospital Nancy France

Study Overview

Official Title: Level of Deprivation Assessment in the Population of Short-bowel Syndrome With Intestinal Failure Patients Monitored by the Nancy University Hospital France Between 2020 and 2023
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PRECAR-SGC
Brief Summary: The association between social deprivation and chronic disease is regularly examined but there are no data available on patients with intestinal failure due to short bowel syndrome SBS-IF First the investigators aim to characterize this population and then to assess if insecurity is associated with some disease criteria
Detailed Description: This exploratory cross-sectional study was conducted on patients affected by intestinal failure in short bowel syndrome and monitored by the certified home parenteral nutrition HPN center of Nancy University Hospital

The investigators included all patients over 18 years old suffering from SBS-IF followed-up by the certified HPN center of Nancy University Hospital between March 1st 2020 and November 30th 2023

The f-EDI a European ecological index adapted to France was determined for each participant

The investigators set the initial date at 2020 as this corresponds to the start of the use of patient-specific formulas in the center Exclusion criteria were not living in France because its required to use French-EDI and patients under 18 years old because they are monitored by the childrens hospital Investigators also excluded patients with transitory type 1 SBS who would have a bowel length over 2 meters after re-establishment of digestive continuity

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None